Mehran Soltani

Mehran Soltani

Auto-generated profile, based on publicly available information

Mehran Soltani

Department of Chemical Engineering, Brigham Young University, Provo, UT, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2021 in New Biotechnology
Verified
Journal Article
Open access
JHJ. Porter Hunt
J. Porter Hunt
EZEmily Long Zhao
Emily Long Zhao
TFTyler J. Free
Tyler J. Free
MSMehran Soltani
Mehran Soltani
CWChandler Warr
Chandler Warr
BBBradley Charles Bundy
Bradley Charles Bundy
Illustration of the assembly, distribution, and point-of-care use of a rapidly-deployable, cell-free COVID-19 biosensor: 1) Assemble: Assembling CFPS reagents by mixing E. coli lysate, murine RNase Inhibitor (mRI), energy sources, cofactors, and toehold switch riboregulator plasmid. 2) Print: aliquoting CFPS reagents onto paper substrates housed in a plastic test cassette. 3) Dehydrate: lyophilizing CFPS reagents on paper substrates. 4) Distribute. 5) Saliva sample: applying saliva samples onto cassette without pretreatments. 6) Reaction: bioluminescent protein expression in presence of target RNA (+), or ribosome detachment in absence of target RNA (-). 7) Visual result: bioluminescent output in the presence of target RNA and NanoLuc luciferase expression.

29 June 2021 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
MSMehran Soltani
Mehran Soltani
JHJ. Porter Hunt
J. Porter Hunt
BBBradley Charles Bundy
Bradley Charles Bundy

1 December 2019 in Synthetic and Systems Biotechnology
Verified
Journal Article
Open access
JHJ. Porter Hunt
J. Porter Hunt
EZEmily Long Zhao
Emily Long Zhao
MSMehran Soltani
Mehran Soltani
MFMadison Frei
Madison Frei
JNJ. Andrew D. Nelson
J. Andrew D. Nelson
BBBradley Charles Bundy
Bradley Charles Bundy
An "endotoxin-free" E. coli-based cell-free protein synthesis system has been reported to produce therapeutic proteins rapidly and on-demand. However, preparation of the most complex CFPS reagent - the cell extract - remains time-consuming and labor-intensive because of the relatively slow growth kinetics of the endotoxin-free ClearColiTMBL21(DE3) strain. Here we report a streamlined procedure for preparing E. coli cell extract from ClearColi™ using auto-induction media. In this work, the term auto-induction describes cell culture media which eliminates the need for manual induction of protein expression. Culturing Clearcoli™ cells in autoinduction media significantly reduces the hands-on time required during extract preparation, and the resulting "endotoxin-free" cell extract maintained the same cell-free protein synthesis capability as extract produced with traditional induction as demonstrated by the high-yield expression of crisantaspase, an FDA approved leukemia therapeutic. It is anticipated that this work will lower the barrier for researchers to enter the field and use this technology as the method to produce endotoxin-free E. coli-based extract for CFPS.

1 January 2022 in Biochemical Engineering Journal
Verified
Journal Article
Closed access
MSMehran Soltani
Mehran Soltani
BBBradley C. Bundy
Bradley C. Bundy

18 February 2021 in The Journal of Chemical Physics
Verified
Journal Article
Closed access
PDF file
ASAddison K. Smith
Addison K. Smith
MSMehran Soltani
Mehran Soltani
JWJoshua W. Wilkerson
Joshua W. Wilkerson
BTBrandon D. Timmerman
Brandon D. Timmerman
EZEmily Long Zhao
Emily Long Zhao
TKThomas A. Knotts
Thomas A. Knotts
PEGylated and surface-tethered proteins are used in a variety of biotechnological applications, but traditional methods offer little control over the placement of the functionalization sites on the protein. Fortunately, recent experimental methods functionalize the protein at any location on the amino acid sequence, so the question becomes one of selecting the site that will result in the best protein function. This work shows how molecular simulation can be used to screen potential attachment sites for surface tethering or PEGylation. Previous simulation work has shown promise in this regard for a model protein, but these studies are limited to screening only a few of the surface-accessible sites or only considered surface tethering or PEGylation separately rather than their combined effects. This work is done to overcome these limitations by screening all surface-accessible functionalization sites on a protein of industrial and therapeutic importance (TEM-1) and to evaluate the effects of tethering and PEGylation simultaneously in an effort to create a more accurate screen. The results show that functionalization site effectiveness appears to be a function of super-secondary and tertiary structures rather than the primary structure, as is often currently assumed. Moreover, sites in the middle of secondary structure elements, and not only those in loops regions, are shown to be good options for functionalization—a fact not appreciated in current practice. Taken as a whole, the results show how rigorous molecular simulation can be done to identify candidate amino acids for functionalization on a protein to facilitate the rational design of protein devices.

16 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMehran Soltani
Mehran Soltani
JSJames R. Swartz
James R. Swartz
Sm Endonuclease (SmEn) is a promiscuous, highly active nuclease widely used in protein purification, 2D protein gels, and gene and cell therapy. We aimed to recombinantly and economically produce this reagent using E. coli. Despite widespread application of E. coli for recombinant production of proteins, cytoplasmic expression of this protein resulted in no activity accumulation. We therefore investigated translocation of SmEn to the periplasm of E. coli by evaluating several signal sequences, E. coli host cells, and incubation conditions. For rapid feedback, we developed a crude lysate-based nuclease activity assay that enabled convenient screening and identified suitable conditions for active SmEn accumulation. Signal sequence selection was most influential with additional benefit gained by slowing synthesis either using the transcriptionally weakened strain, C43 (DE3) or by reducing incubation temperature. While our study provides valuable insights for optimizing a nuclease translocation and reducing production costs, more research is needed to explore the influence of mRNA secondary structure at the translation initiation region on protein expression and translocation. Overall, our rapid screening assay facilitated the development of an effective production process for a protein with potential cytoplasmic toxicity as well as the need of disulfide bond formation.